Electrical Engineering Dept, California Institute of Technology, Pasadena, 91125, United States.
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jan 15;878(2):258-63. doi: 10.1016/j.jchromb.2009.08.038. Epub 2009 Aug 29.
Herein we report on a proof of principle for the reproducible quantification of Vascular Endothelial Growth Factor (VEGF) in human plasma by fluorescence sandwich immunoassays using disposable polydimethylsiloxane (PDMS) microfluidic chips. The system requires 100 times less sample than typical clinical blood tests, while its current quantification limit is established at 4pM. The in-built calibration method of spiking the plasma with known concentrations of commercially available antigen avoids common sources of error and improves the reliability of the test results. The demonstrated technique is important for immunoassay applications in fundamental scientific research and "point-of-care" (POC) biomedical diagnostics. In particular, the system is immediately applicable to microfluidic quantification of VEGF in human plasma in cancer studies.
在此,我们报告了一种原理验证,即通过使用一次性聚二甲基硅氧烷(PDMS)微流控芯片的荧光夹心免疫分析,可在人类血浆中重现定量血管内皮生长因子(VEGF)。该系统所需的样本量比典型的临床血液测试少 100 倍,而其当前的定量下限设定为 4pM。通过向血浆中添加已知浓度的市售抗原进行内建校准的方法,避免了常见的误差源,提高了测试结果的可靠性。所展示的技术对于基础科学研究和“即时检测”(POC)生物医学诊断中的免疫分析应用非常重要。特别是,该系统可立即应用于癌症研究中人类血浆中 VEGF 的微流体定量。